<DOC>
	<DOCNO>NCT00568854</DOCNO>
	<brief_summary>The study hypothesis type 2 diabetic abnormal cell-mediated immunity tuberculosis manifesting alter cytokine response peripheral blood mononuclear cell ( PBMCs ) . This hypothesis test use live tuberculosis vaccine , Bacille Calmette-Guerin ( BCG ) , U.S.-born type 2 diabetic nondiabetics . The investigator control potential confounding age , sex , race , comorbidities , select medication . Expression key cytokine measure real-time polymerase chain reaction .</brief_summary>
	<brief_title>Immunobiology Diabetes Tuberculosis</brief_title>
	<detailed_description>The project three specific aim : Specific Aim 1 : To assess difference study group cytokine expression BCG vaccination . The investigator determine within-individual variability cytokine measurement describe kinetics cytokine response BCG . Peak response level , time peak , pattern cytokine express compare . Specific Aim 2 : To evaluate effect hyperglycemia cytokine response type 2 diabetic . The investigator evaluate whether level hemoglobin A1C ( HbA1C ) associate degree cytokine response test type 2 diabetic good glucose control different nondiabetics . Specific Aim 3 : To evaluate effect test PBMCs diabetic outside diabetic milieu . Investigators compare BCG-specific cytokine response PBMCs stimulate normal medium , PBMCs stimulate glucose correlate person 's recent HbA1C , whole blood sample .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>Type 2 diabetes healthy individual Able give consent USborn Age 3065 * Immunosuppressive disease Immunosuppressive medication Pregnancy Renal failure Advanced pulmonary disease Prior BCG vaccination Prior TB infection Type 1 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>